CIPHORE BIOMED TECHNOLOGY CO., LTD.
Update：2026/09/15
Industries
Main Industry
Consumer Goods
Main Product/Service
Creams, facial masks, serums, and medical beauty ampoules
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2016
Unified Business No.
42855393
Status
Active
Number of Employees
0
Total Paid-in
Capital
0 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Ciphore Biotech has developed several unique cyclic peptide biomedical targets that can further enhance creams, facial masks, serums, and medical beauty ampoules for facial, neck, and skin care, enabling stem cells to restore the collagen layer in the tissue. This achieves wrinkle minimization and brightening in facial tissues. To date, five different types of biomimetic cyclic peptides have been developed. Since May 2016, these have entered the international market under the Ciphôré trademark and as a new corporate venture. Currently, several cyclic peptides for the knee cartilage layer are being formulated as maintenance patches.
(The content above was translated by AI.)
(The content above was translated by AI.)
